Paliperidone (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Paliperidone drug offered from Mylan Institutional Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | paliperidone |
| SUBSTANCE NAME: | PALIPERIDONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-20 |
| END MARKETING DATE: | 0000-00-00 |
Paliperidone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Paliperidone from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3(mg/1) |
| START MARKETING DATE: | 2016-09-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42292-026_5bed7cb1-1ea7-202e-e053-2a91aa0a9886 |
| PRODUCT NDC: | 42292-026 |
| APPLICATION NUMBER: | ANDA203802 |
Other PALIPERIDONE Pharmaceutical Manufacturers / Labelers:
